Alteration of subgingival microbiome in patients with type 2 diabetes induced by diabetes treatment
ABSTRACT Aims/Introduction Diabetes and periodontal disease, a bacterial infection involving the oral microbiome, have a bidirectional relationship. However, the relationship between poor glycemic control and the oral microbiome remains unclear. The aim of this study was to assess the direct effect of intensive glycemic control on the oral microbiome ...
Moe Inoue +13 more
wiley +1 more source
Dietary advanced glycation end products (AGEs) and type 2 diabetes (T2D): a case-control study. [PDF]
Salman Alharbi S +6 more
europepmc +1 more source
ABSTRACT Aims Residual albuminuria remains a major clinical challenge in patients with type 2 diabetes mellitus and hypertension despite renin–angiotensin system inhibitor therapy. Esaxerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, reduces albuminuria; however, its effects on oxidative stress remain unclear.
Makoto Ohara +9 more
wiley +1 more source
Close relationship between β2‐microglobulin and type 2 diabetes‐associated peripheral neuropathy
ABSTRACT Aims/Introduction This study aimed to elucidate the correlation between β2‐microglobulin (β2‐MG) and peripheral neuropathy in type 2 diabetes mellitus (T2DM). Materials and Methods Diabetic peripheral neuropathy (DPN) was defined on the nerve conduction study (NCS).
Jingfang Shao +3 more
wiley +1 more source
Effects of Advanced Glycation End Products (AGEs) on Human Lung Macrophages: Implications for Pulmonary Inflammation. [PDF]
Palestra F +15 more
europepmc +1 more source
Are Inflamed Periodontal Tissues Endogenous Source of Advanced Glycation End-Products (AGEs) in Individuals with and without Diabetes Mellitus? A Systematic Review. [PDF]
Chopra A, Jayasinghe TN, Eberhard J.
europepmc +1 more source
SGLT2i use and fracture risk compared with DPP4i in patients with T2DM
ABSTRACT Introduction The association between sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) use and fracture risk remains inconclusive. Most previous studies have focused on treatment‐naïve patients, despite many patients in routine clinical practice initiating SGLT2i therapy after prior dipeptidyl peptidase‐4 inhibitor (DPP4i) use.
Sung‐Yen Lin +5 more
wiley +1 more source
Abstract: Perceived Facial Aging: The Role of AGES (Advanced Glycation End Products)
Jonathan Y. Lee, MD, MPH +3 more
doaj +1 more source
Are Dietary and Serum Advanced Glycation End Products (AGEs) Potential Contributors to Inflammation in Women with Polycystic Ovary Syndrome? [PDF]
Yurt M, Gökmen-Özel H.
europepmc +1 more source
Effects of baking factors and recipes on the quality of butter cookies and the formation of advanced glycation end products (AGEs) and 5-hydroxymethylfurfural (HMF). [PDF]
Hu H +6 more
europepmc +1 more source

